Sagliker syndrome
sah-glee-ker sin-drohm
Also known as: Sagliker disease, Renal osteodystrophy with craniofacial abnormalities
At a Glance
What is Sagliker syndrome?
Sagliker syndrome is a rare disorder that primarily affects individuals with chronic kidney disease. It is characterized by severe bone deformities, particularly in the face and skull, due to secondary hyperparathyroidism. This condition arises when the parathyroid glands produce too much hormone in response to low calcium levels, often seen in kidney failure. Over time, the excess hormone causes bones to weaken and deform. Early symptoms may include facial changes and dental issues, while later stages can involve severe skeletal deformities. Early diagnosis is crucial to manage symptoms and prevent progression. The condition can significantly impact family life due to the need for ongoing medical care and potential physical disabilities. Prognosis varies depending on the severity of kidney disease and the effectiveness of treatment. Daily life for affected individuals may involve regular dialysis, medication, and possibly surgery to manage symptoms. Supportive care and physical therapy can help improve quality of life. Despite its challenges, many individuals can lead fulfilling lives with appropriate medical management.
Medical Definition
Sagliker syndrome is a rare condition associated with chronic kidney disease and secondary hyperparathyroidism, leading to severe skeletal deformities. Pathologically, it involves excessive parathyroid hormone production causing bone resorption and abnormal bone growth. Histological findings include fibrous osteitis and marrow fibrosis. It is classified under renal osteodystrophy with craniofacial abnormalities. Epidemiologically, it is extremely rare, with cases primarily reported in individuals with end-stage renal disease. The disease course is progressive, with worsening skeletal deformities if not adequately managed.
Sagliker syndrome Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Facial disfigurement in Sagliker syndrome manifests as craniofacial abnormalities, including prominent forehead and jaw deformities. This occurs due to excessive bone resorption and deposition caused by secondary hyperparathyroidism. Over time, these changes can become more pronounced, leading to significant cosmetic concerns. Patients often experience social and psychological impacts, and surgical interventions may be considered to improve appearance.
Dental abnormalities include malocclusion, tooth loss, and enamel hypoplasia. These issues arise due to altered calcium and phosphate metabolism affecting dental development. As the condition progresses, dental health may deteriorate, leading to difficulties in chewing and increased risk of infections. Regular dental care and corrective procedures can help manage these symptoms.
Bone pain is a common symptom, often presenting as diffuse aches and discomfort in the limbs and spine. It is primarily caused by osteitis fibrosa cystica, a result of excessive parathyroid hormone activity. The pain can worsen with time, affecting mobility and quality of life. Pain management strategies, including medication and physical therapy, are essential for patient comfort.
Common
Short stature is frequently observed due to impaired growth plate development and bone maturation. This is linked to chronic kidney disease and secondary hyperparathyroidism affecting growth hormone pathways. Growth retardation becomes more evident as the child ages, potentially leading to psychosocial challenges. Growth hormone therapy and nutritional support may be beneficial in managing this symptom.
Hearing loss in Sagliker syndrome can range from mild to severe and is often conductive in nature. It is attributed to structural changes in the bones of the middle ear and cranial base. Over time, hearing impairment can impact communication and social interactions. Hearing aids and surgical interventions may be employed to improve auditory function.
Muscle weakness is characterized by reduced muscle strength and endurance, often affecting daily activities. It results from electrolyte imbalances and muscle wasting associated with chronic kidney disease. As the condition progresses, patients may experience increased fatigue and difficulty performing physical tasks. Physical therapy and nutritional support can help improve muscle function.
Less Common
Skin changes may include pruritus, dryness, and hyperpigmentation. These alterations are linked to the accumulation of uremic toxins and altered mineral metabolism. Over time, skin symptoms can lead to discomfort and increased risk of infections. Topical treatments and systemic therapies can help alleviate these skin-related issues.
Neurological symptoms may present as cognitive impairment, peripheral neuropathy, or seizures. These are caused by metabolic imbalances and the accumulation of toxins due to renal failure. As the disease advances, neurological issues can significantly impair daily functioning and quality of life. Comprehensive management, including medication and supportive therapies, is crucial for addressing these symptoms.
What Causes Sagliker syndrome?
Sagliker syndrome is primarily associated with mutations in the CASR gene located on chromosome 3q13.3-q21. The CASR gene encodes the calcium-sensing receptor, which is crucial for maintaining calcium homeostasis in the body. Mutations in this gene can lead to a dysfunctional receptor that fails to properly regulate calcium levels. This disruption in calcium regulation causes an imbalance in calcium and phosphate metabolism, leading to secondary hyperparathyroidism. The excess parathyroid hormone (PTH) secretion results in increased bone resorption and abnormal bone remodeling. This can cause fibrous dysplasia and osteitis fibrosa cystica, leading to skeletal deformities. The altered bone structure and mineral imbalance can affect surrounding tissues, causing pain and deformities. Additionally, the chronic imbalance in calcium can trigger neuroinflammation and an immune response, exacerbating symptoms. Over time, the degeneration of white matter and other neural structures may occur due to prolonged metabolic disturbances. Symptoms often appear in a specific pattern due to the progressive nature of bone and tissue changes. The severity of the disease varies between patients due to differences in genetic background, environmental factors, and the extent of receptor dysfunction. Some patients may experience more severe skeletal deformities, while others may have more pronounced renal or neurological symptoms. The variability in clinical presentation is also influenced by the degree of secondary hyperparathyroidism and the body's compensatory mechanisms.
How is Sagliker syndrome Diagnosed?
Typical age of diagnosis: Sagliker syndrome is typically diagnosed in young adults who present with characteristic facial and skeletal deformities, often in the context of chronic kidney disease and secondary hyperparathyroidism.
Clinicians look for craniofacial deformities, dental abnormalities, and short stature. A detailed history of chronic kidney disease and secondary hyperparathyroidism is crucial. Physical examination may reveal bone deformities and growth retardation. This step helps in differentiating Sagliker syndrome from other skeletal dysplasias.
X-rays and CT scans are commonly used to visualize skeletal abnormalities. Specific findings include craniofacial deformities and osteitis fibrosa cystica. These imaging results support the diagnosis of Sagliker syndrome by highlighting characteristic bone changes. Differential diagnoses such as osteomalacia and Paget's disease are excluded based on imaging patterns.
Serum calcium, phosphate, and parathyroid hormone levels are measured. Elevated parathyroid hormone and abnormal calcium-phosphate balance are indicative. These abnormal results confirm secondary hyperparathyroidism. Laboratory findings guide further management and monitoring of metabolic abnormalities.
Genetic testing may involve sequencing genes related to renal and skeletal development. Mutations in genes affecting parathyroid hormone regulation can be identified. Positive results confirm the diagnosis and help in understanding the genetic basis. Genetic counseling is informed by these results, aiding family planning.
Sagliker syndrome Treatment Options
Calcimimetics are used to manage secondary hyperparathyroidism. They work by increasing the sensitivity of the parathyroid gland to calcium, thereby reducing parathyroid hormone levels. Cinacalcet is a specific drug used in this context. Clinical studies have shown efficacy in reducing parathyroid hormone levels and improving bone health. Side effects may include gastrointestinal disturbances and hypocalcemia.
Techniques include strength training and range-of-motion exercises. The goal is to improve mobility and reduce pain associated with skeletal deformities. Sessions are typically conducted 2-3 times weekly for several months. Outcomes are measured by improved joint function and reduced pain scores. Long-term benefits include enhanced quality of life and functional independence.
Indicated for severe hyperparathyroidism unresponsive to medical therapy. The procedure involves the removal of hyperactive parathyroid glands. Benefits include normalization of parathyroid hormone levels and alleviation of bone pain. Surgical risks include hypocalcemia and recurrent laryngeal nerve injury. Post-operative care involves calcium and vitamin D supplementation.
The team includes nephrologists, endocrinologists, orthopedic surgeons, and physiotherapists. Interventions focus on managing renal function, bone health, and nutritional status. Psychosocial support includes counseling and community resources. Family education covers disease management and genetic implications. Long-term monitoring involves regular follow-ups and adjustment of treatment plans.
When to See a Doctor for Sagliker syndrome
- Severe facial deformities — these may indicate advanced disease progression requiring immediate medical intervention.
- Uncontrolled seizures — this can be life-threatening and requires emergency care.
- Sudden loss of consciousness — this may signal a critical complication and needs urgent evaluation.
- Persistent bone pain — may indicate worsening bone disease; consult a healthcare provider for assessment.
- Progressive vision changes — could suggest complications affecting the eyes; seek ophthalmologic evaluation.
- Increasing fatigue — may be a sign of worsening renal function or other systemic issues; discuss with a doctor.
- Mild joint stiffness — monitor for changes and manage with gentle exercises at home.
- Occasional headaches — keep track of frequency and intensity, and consult a doctor if they worsen.
Sagliker syndrome — Frequently Asked Questions
Is this condition hereditary?
Sagliker syndrome is not typically considered hereditary, as it is primarily associated with secondary hyperparathyroidism due to chronic kidney disease. There is no established inheritance pattern, and the probability of passing it to children is low. De novo mutations are not a recognized factor in its development. Carrier status does not apply, as it is not a genetic disorder in the traditional sense. Genetic counseling is not usually necessary, but may be considered for related renal conditions.
What is the life expectancy for someone with this condition?
Life expectancy varies depending on the age of onset and the effectiveness of managing underlying conditions like renal disease. Poorly controlled secondary hyperparathyroidism can worsen outcomes. Mortality is often related to complications such as cardiovascular disease or severe bone deformities. Effective treatment of the underlying kidney disease and parathyroid management can improve survival rates. Patients should have realistic expectations about managing chronic symptoms and potential complications.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves a combination of clinical evaluation, imaging studies, and laboratory tests to assess parathyroid hormone levels and renal function. The time from first symptoms to diagnosis can vary, often taking months to years due to the complexity of symptoms. Nephrologists and endocrinologists are typically consulted. Delays in diagnosis are common due to symptom overlap with other conditions. Confirmation is usually achieved through a combination of clinical findings and biochemical tests.
Are there any new treatments or clinical trials available?
Current research is focused on better management of secondary hyperparathyroidism and its complications. Novel approaches like gene therapy are not yet applicable, but advancements in renal disease treatments are promising. Clinical trials can be found on ClinicalTrials.gov by searching for related terms like 'secondary hyperparathyroidism' and 'chronic kidney disease.' Patients should ask their doctors about eligibility for ongoing trials. New treatments may take several years to become widely available.
How does this condition affect daily life and activities?
Sagliker syndrome can significantly impact mobility and self-care due to bone deformities and pain. Educational and occupational activities may be affected by physical limitations and frequent medical appointments. Social and emotional challenges include coping with visible deformities and chronic illness. The condition can place a significant burden on families, requiring adaptations in daily routines. Supportive therapies and assistive devices can help improve quality of life.
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Sagliker Syndrome.
Rubio-Manzanares Dorado M, Pino Díaz V, Fontillón Alberdi M et al. · Cir Esp (Engl Ed) · 2020 · PMID: 31836134
- 2.[A case of Sagliker syndrome and literature review].
Wu W, Qian L, Chen X et al. · Zhong Nan Da Xue Xue Bao Yi Xue Ban · 2014 · PMID: 25355264
- 3.Sagliker syndrome in a patient with end-stage renal disease with secondary hyperparathyroidism.
Panezai MA, Ahmed S, Colbert GB · Proc (Bayl Univ Med Cent) · 2019 · PMID: 31656444
- 4.Bone and Parathyroid Scintigraphy Findings in Sagliker Syndrome.
Erol Ç, Şahin Ö, Şen AE et al. · Mol Imaging Radionucl Ther · 2024 · PMID: 38390778
- 5.Sagliker Syndrome in a Patient With Secondary Hyperparathyroidism and Chronic Kidney Disease: A Case Report From Palestine.
Ahmad I, Alkomi S, Sharaha R et al. · Cureus · 2024 · PMID: 38333487
- 6.Clinical status of Sagliker syndrome: a case report and literature review.
Chen XH, Shen B, Zou J et al. · Ren Fail · 2014 · PMID: 24575953
- 7.Sagliker syndrome in a patient with end-stage renal disease and uncontrolled secondary hyperparathyroidism.
Ru Y, Xue L, Zhu MG et al. · Clin Nephrol · 2024 · PMID: 38836368
- 8.Sagliker syndrome: first four cases in Bulgaria.
Cholakova R, Pechalova P, Kapon E · G Ital Nefrol · 2016 · PMID: 27545627
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-04-30